Psychedelics research and manufacturing company Optimi Health Corp. (OTCQX: OPTHF) received a “Natural Health Product Site" license, adding to its existing permits to produce and supply psychedelic substances including MDMA and psilocybin.

See also: Another Company Approved To Begin Production Of Psychedelics Under Canadian Dealers License

Following an assessment by Health Canada’s Natural and Non-prescription Health Products directorate and under section 29 of the Natural Health Products Regulations, the expanded licensing now allows Optimi to manufacture …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.